LoadingLoadingLoadingThe quick read
Latest quote·Oct 12
Net selling: insiders sold $16K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $16K and bought $0 of IMNN stock on the open market in the 90 days to Oct 13, 2026, according to SEC Form 4 filings. The largest was Eylward, Susan (General Counsel and Corp Sec), who sold $16K. The latest filing was on Sep 1, 2026.
None. No member of Congress disclosed a IMNN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
3 funds hold a position and insiders have been net selling.
No tracked top-trader positions in IMNN right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.94 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | -$0.54 / -$0.94Alpha Vantage | +42.55% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 12, 2026 | -$0.84 / -$1.28Alpha Vantage | +34.38% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 31, 2026 | -$1.30 / -$1.82Alpha Vantage | +28.57% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 13, 2025 | -$1.16 / -$1.82Alpha Vantage | +36.26% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | -$1.87 / -$4.34Alpha Vantage | +56.91% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 12, 2025 | -$3.65 / -$4.66Alpha Vantage | +21.67% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | -$0.25 / -$0.36Alpha Vantage | +30.56% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | -$4.43 / -$5.35Alpha Vantage | +17.20% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | -$725.2K | $0 |
| Cost of what it sold | $164.7K | $167.0K | $169.3K | $166.5K |
| Gross profit | -$164.7K | -$167.0K | -$169.3K | -$166.5K |
| What it spent | ||||
| Research and development | $1.2M | $1.9M | $2.5M | $2.3M |
| Sales and admin | $1.5M | $1.6M | $1.8M | $1.97B |
| Other operating costs | -$164.7K | — | — | -$1.97B |
| Total operating expenses | $2.6M | $3.5M | $4.3M | $4.1M |
| What was left | ||||
| Operating profit | -$2.8M | -$3.5M | -$4.3M | -$4.3M |
| Profit before tax | -$2.7M | -$3.4M | -$4.2M | -$4.2M |
| Net profit | -$2.7M | -$3.4M | -$4.2M | -$4.2M |
| EBITDA | -$2.6M | -$3.3M | -$4.1M | -$4.1M |
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
